Top Up Jab Bookings to Open Up For More Than One Million People
More than one million people will be eligible to book their life-saving jab top-up from tomorrow, as the NHS Covid-19 Vaccination programme continues to boost people’s protection ahead of winter.
From 7am tomorrow (Monday 22 November), people aged 40 to 49 will be able to book their booster vaccine, and 16 and 17-year-olds their second jabs, just seven days after the JCVI updated their advice for these age groups.
Almost 500,000 people in their forties had their second dose at least six months ago, and are currently eligible to get their booster jab.
People can book their booster appointment on the National Booking Service a month before they become eligible, which means they can get their top-up jabs as soon as they reach the six month mark.
There are more than one million 40 to 49-year-olds who will be able to pre-book their booster appointments tomorrow, and a further 1.5 million invites are being sent to this age group in coming weeks.
Young people aged 16 and 17 can also book their second vaccine online from tomorrow, following last week’s updated JCVI guidance recommending a second dose at least 12 weeks after their first.
Nearly 200,000 people in this age group are already eligible for a second dose, and invitations for second jabs will be landing on the doorsteps of thousands of 16 and 17-year-olds over the next few weeks.
Almost 800,000 in this age group have had their first Covid jab since the biggest and most successful vaccination programme in health history rolled out to this age group in summer.
More than 12 million boosters have been delivered in total since the booster campaign kicked off in September, less than 48 hours after updated JCVI guidance.
Thanks to the efforts of NHS staff and volunteers, more than 93 million jabs have been delivered since Margaret Keenan had the first vaccination in the world outside clinical trials in Coventry last December.
England’s top doctor today urged those in newly eligible groups to come forward as soon as they are eligible for the top up protection against the virus.
Professor Stephen Powis, NHS national medical director, said: “Thanks to the incredible efforts of NHS staff and volunteers more than 12 million boosters have been delivered in less than 10 weeks since the NHS rolled out the programme within 48 hours of updated guidance.
“The NHS has once again been quick to roll out to newly eligible groups, including protecting people in their forties with a booster and providing second doses to young people, with hundreds of thousands of invites landing over the next few weeks.
“I’ve had my booster and I would urge everyone to get their vaccine whether their first, second or top-up dose as soon as possible, giving them and their loved ones vital protection over winter and the festive period.”
Since the NHS in England made history with the first Covid-19 vaccination delivered outside a clinical trial in December 2020, more than 93 million doses of the life-saving vaccine have been delivered – with more than nine in 10 adults having had their first vaccination.
The NHS is vaccinating in line with Joint Committee on Vaccination and Immunisation (JCVI) guidance, which was updated to include people aged 40 to 49 getting a booster, as well as recommending a second dose for 16 and 17-year-olds 12 weeks after receiving their first dose.
UKHSA has advised that where people have had Covid-19, people over 18 or under 18 and at higher risk will need to wait four weeks from the onset of symptoms or a positive test result before getting the vaccine, and people under 18 not at higher risk will need to wait at least 12 weeks.
People can get their vaccine by booking online through the national booking service or by calling 119, and GP practices are also inviting those who are eligible.
There are more places delivering vaccines now than at any other point in the programme, including pharmacies, GP practices and other community sites, meaning the vast majority of people live within 10 miles of a fixed vaccination clinic.
People In This Post
Companies In This Post
- Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
- Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
- Companion Spine Closes $60.1 Million Series A Funding Round Read more
- EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
- Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more